Stay updated with breaking news from Rapid Communication. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a Rapid Communication issued today, the World Health Organization (WHO) is announcing updates on co-administration of treatment for drug-resistant tuberculosis and hepatitis C (HCV). The evidence suggests that concomitant treatment for HCV and multi-drug resistant or rifampicin resistant TB (MDR/RR-TB) is feasible, with
/PRNewswire/ -- Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial stage biotechnology company, today announced presentations and posters to be shared at...
The National Comprehensive Cancer Network updated its recommendations to include Krazati for patients with KRAS G12-mutant pancreatic cancer.
LYON, France and CAMBRIDGE, Mass., May 05, 2023 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced
/PRNewswire/ -- Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial stage biotechnology company, announced today the Journal of Clinical Oncology published...